Anika Therapeutics Inc. (ANIK) Stock: Dividends & Earnings

Company Overview:

Market Cap: $260.00M

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $8.67 - $22.88

10 Year ANIK Performance Metrics:

Total Return (with DRIP): -59.3% (-8.60% CAGR)

Total Return (no DRIP): -59.3% (-8.60% CAGR)

Share Price: -59.3% (-8.60% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $4,071

Total Return $ (with DRIP): -$5,929

ANIK Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

ANIK Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for ANIK

Based on past 10-year performance, here are ANIK growth metrics:

Share price CAGR of -8.65%
Dividend CAGR of +0%

Using ANIK CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	ANIK (DRIP)	ANIK - No DRIP
Current Price	$19.36	$19.36
Start Shares	516.53	516.53
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	516.53	516.53
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$7.83	$19.36
Total Dividends	$0	$0
Final Value	$4,046	$10,000

Estimated Future Value + Dividends - ANIK

NOTE: Above numbers are our estimate based on ANIK's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Anika Therapeutics Inc. (ANIK) had its IPO on , and is traded on NASDAQ stock exchange.

Anika Therapeutics Inc. is a medical technology company focused on joint preservation and early intervention orthopedics. The company develops, manufactures, and commercializes hyaluronic acid-based products used in osteoarthritis pain management, regenerative medicine, sports medicine, and soft tissue repair. Its portfolio includes injectable therapies and orthopedic solutions designed to support mobility, tissue healing, and minimally invasive care for patients with degenerative joint conditions and musculoskeletal injuries. Anika Therapeutics serves healthcare professionals and clinical settings across the United States, Europe, and other international markets, with products used in orthopedics and related surgical applications. Headquartered in Bedford, Massachusetts, Anika Therapeutics Inc. plays a specialized role in the musculoskeletal care market by offering therapies and biomaterials that address joint health, cartilage repair, and recovery support.

ANIK website: https://www.anika.com